Skip to main content
Top
Published in: Journal of Genetic Counseling 3/2012

01-06-2012 | Case Study

Direct-to-Consumer Personal Genomic Testing: A Case Study and Practical Recommendations for “Genomic Counseling”

Authors: Amy C. Sturm, Kandamurugu Manickam

Published in: Journal of Genetic Counseling | Issue 3/2012

Login to get access

Abstract

Technological advances and information-seeking consumers have pushed forward the movement of direct-to-consumer (DTC) genetic testing. Just like with other types of testing, there are potential risks, benefits and limitations. A major limitation of DTC testing is the incomplete view it provides regarding lifetime risk for common, complex diseases, since most tests only analyze 1–2 single nucleotide polymorphisms (SNPs) and do not include evaluation of medical or family histories, which is necessary to risk assessment. Further, it is not currently well-established whether personal genomic testing results will lead toward improved health behaviors, adverse psychological effects or potential overuse of the health care system. To display these and other issues, we present an in-depth case study of an individual who ordered DTC genetic testing and subsequently sought genetic counseling. This case presents a unique learning experience for the field of genomic counseling, as the patient did not fit the typical assumptions regarding ‘early adopters’ of DTC testing. It also allowed the genetics health care providers involved in the case to identify gaps in current genetic counseling practice that need to be filled and approaches to employ for successful delivery of genomic counseling. Based on our experience, we developed practical recommendations for genomic counseling, which include novel approaches to case preparation, use of electronic tools during the counseling session, and focusing on education as the major component of the genomic counseling session, in order to provide patients with the knowledge necessary to independently interpret and understand large amounts of genomic testing information provided to them.
Literature
go back to reference Abnet, C. C., Freedman, N. D., Hu, N., Wang, Z., Yu, K., Shu, X. O., et al. (2010). A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nature Genetics, 42(9), 764–767.PubMedCrossRef Abnet, C. C., Freedman, N. D., Hu, N., Wang, Z., Yu, K., Shu, X. O., et al. (2010). A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nature Genetics, 42(9), 764–767.PubMedCrossRef
go back to reference Alexander, J., & Kowdley, K. V. (2009). HFE-associated hereditary hemochromatosis. Genetics in Medicine, 11(5), 307–313.PubMedCrossRef Alexander, J., & Kowdley, K. V. (2009). HFE-associated hereditary hemochromatosis. Genetics in Medicine, 11(5), 307–313.PubMedCrossRef
go back to reference Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524–534.PubMedCrossRef Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524–534.PubMedCrossRef
go back to reference Borry, P., Cornel, M. C., & Howard, H. C. (2010). Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. Journal of Community Genetics, 1(3), 101–106.PubMedCrossRef Borry, P., Cornel, M. C., & Howard, H. C. (2010). Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. Journal of Community Genetics, 1(3), 101–106.PubMedCrossRef
go back to reference Bowen, D. J., Battuello, K. M., & Raats, M. (2005). Marketing genetic tests: empowerment or snake oil? Health Education & Behavior, 32(5), 676–685.CrossRef Bowen, D. J., Battuello, K. M., & Raats, M. (2005). Marketing genetic tests: empowerment or snake oil? Health Education & Behavior, 32(5), 676–685.CrossRef
go back to reference Cameron, L. D., Sherman, K. A., Marteau, T. M., & Brown, P. M. (2009). Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychology, 28(3), 307–316.PubMedCrossRef Cameron, L. D., Sherman, K. A., Marteau, T. M., & Brown, P. M. (2009). Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychology, 28(3), 307–316.PubMedCrossRef
go back to reference Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Disease and Associated Disorders, 22(1), 94–97.PubMedCrossRef Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Disease and Associated Disorders, 22(1), 94–97.PubMedCrossRef
go back to reference Dhillon, P. K., Farrow, D. C., Vaughan, T. L., Chow, W. H., Risch, H. A., Gammon, M. D., et al. (2001). Family history of cancer and risk of esophageal and gastric cancers in the United States. International Journal of Cancer, 93(1), 148–152.CrossRef Dhillon, P. K., Farrow, D. C., Vaughan, T. L., Chow, W. H., Risch, H. A., Gammon, M. D., et al. (2001). Family history of cancer and risk of esophageal and gastric cancers in the United States. International Journal of Cancer, 93(1), 148–152.CrossRef
go back to reference Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574.PubMedCrossRef Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574.PubMedCrossRef
go back to reference Gollust, S. E., Hull, S. C., & Wilfond, B. S. (2002). Limitations of direct-to-consumer advertising for clinical genetic testing. Journal of the American Medical Association, 288(14), 1762–1767.PubMedCrossRef Gollust, S. E., Hull, S. C., & Wilfond, B. S. (2002). Limitations of direct-to-consumer advertising for clinical genetic testing. Journal of the American Medical Association, 288(14), 1762–1767.PubMedCrossRef
go back to reference Gollust, S. E., Gordon, E. S., Zayac, C., Griffin, G., Christman, M. F., Pyeritz, R. E., et al. (2012). Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics, 15, 22–30.PubMedCrossRef Gollust, S. E., Gordon, E. S., Zayac, C., Griffin, G., Christman, M. F., Pyeritz, R. E., et al. (2012). Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics, 15, 22–30.PubMedCrossRef
go back to reference Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., et al. (2009). Disclosure of APOE genotype for risk of Alzheimer’s disease. The New England Journal of Medicine, 361(3), 245–254.PubMedCrossRef Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., et al. (2009). Disclosure of APOE genotype for risk of Alzheimer’s disease. The New England Journal of Medicine, 361(3), 245–254.PubMedCrossRef
go back to reference Gulcher, J., & Stefansson, K. (2010). Genetic risk information for common diseases may indeed be already useful for prevention and early detection. European Journal of Clinical Investigation, 40(1), 56–63.PubMedCrossRef Gulcher, J., & Stefansson, K. (2010). Genetic risk information for common diseases may indeed be already useful for prevention and early detection. European Journal of Clinical Investigation, 40(1), 56–63.PubMedCrossRef
go back to reference Guttmacher, A. E., Porteous, M. E., & McInerney, J. D. (2007). Educating health-care professionals about genetics and genomics. Nature Reviews Genetics, 8(2), 151–157.PubMedCrossRef Guttmacher, A. E., Porteous, M. E., & McInerney, J. D. (2007). Educating health-care professionals about genetics and genomics. Nature Reviews Genetics, 8(2), 151–157.PubMedCrossRef
go back to reference Hamajima, N., Atsuta, Y., Goto, Y., & Ito, H. (2004). A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pacific Journal of Cancer Prevention, 5(4), 409–413.PubMed Hamajima, N., Atsuta, Y., Goto, Y., & Ito, H. (2004). A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pacific Journal of Cancer Prevention, 5(4), 409–413.PubMed
go back to reference Hamajima, N., Suzuki, K., Ito, Y., & Kondo, T. (2006). Genotype announcement to Japanese smokers who attended a health checkup examination. Journal of Epidemiology, 16(1), 45–47.PubMedCrossRef Hamajima, N., Suzuki, K., Ito, Y., & Kondo, T. (2006). Genotype announcement to Japanese smokers who attended a health checkup examination. Journal of Epidemiology, 16(1), 45–47.PubMedCrossRef
go back to reference Ito, H., Matsuo, K., Wakai, K., Saito, T., Kumimoto, H., Okuma, K., et al. (2006). An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Preventive Medicine, 42(2), 102–108.PubMedCrossRef Ito, H., Matsuo, K., Wakai, K., Saito, T., Kumimoto, H., Okuma, K., et al. (2006). An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Preventive Medicine, 42(2), 102–108.PubMedCrossRef
go back to reference Janssens, A. C., Wilde, A. A., & van Langen, I. M. (2011). The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Netherlands Heart Journal, 19(2), 85–88.PubMedCrossRef Janssens, A. C., Wilde, A. A., & van Langen, I. M. (2011). The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Netherlands Heart Journal, 19(2), 85–88.PubMedCrossRef
go back to reference Lagergren, J., Ye, W., Lindgren, A., & Nyren, O. (2000). Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiology, Biomarkers & Prevention, 9(7), 757–760. Lagergren, J., Ye, W., Lindgren, A., & Nyren, O. (2000). Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiology, Biomarkers & Prevention, 9(7), 757–760.
go back to reference Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16(1), 87–99.PubMedCrossRef Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16(1), 87–99.PubMedCrossRef
go back to reference McBride, C. M., Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention, 11(6), 521–528. McBride, C. M., Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention, 11(6), 521–528.
go back to reference McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2008). Putting science over supposition in the arena of personalized genomics. Nature Genetics, 40(8), 939–942.PubMedCrossRef McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2008). Putting science over supposition in the arena of personalized genomics. Nature Genetics, 40(8), 939–942.PubMedCrossRef
go back to reference McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2009). Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genetics in Medicine, 11(8), 582–587.PubMedCrossRef McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2009). Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genetics in Medicine, 11(8), 582–587.PubMedCrossRef
go back to reference McBride, C. M., Koehly, L. M., Sanderson, S. C., & Kaphingst, K. A. (2010). The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annual Review of Public Health, 31, 89–103.PubMedCrossRef McBride, C. M., Koehly, L. M., Sanderson, S. C., & Kaphingst, K. A. (2010). The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annual Review of Public Health, 31, 89–103.PubMedCrossRef
go back to reference McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P., et al. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics, 9(5), 356–369.PubMedCrossRef McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P., et al. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics, 9(5), 356–369.PubMedCrossRef
go back to reference Mihaescu, R., van Hoek, M., Sijbrands, E. J., Uitterlinden, A. G., Witteman, J. C., Hofman, A., et al. (2009). Evaluation of risk prediction updates from commercial genome-wide scans. Genetics in Medicine, 11(8), 588–594.PubMedCrossRef Mihaescu, R., van Hoek, M., Sijbrands, E. J., Uitterlinden, A. G., Witteman, J. C., Hofman, A., et al. (2009). Evaluation of risk prediction updates from commercial genome-wide scans. Genetics in Medicine, 11(8), 588–594.PubMedCrossRef
go back to reference Nelson, E. A., & McGuire, A. L. (2010). The need for medical education reform: genomics and the changing nature of health information. Genome Medicine, 2(3), 18.PubMedCrossRef Nelson, E. A., & McGuire, A. L. (2010). The need for medical education reform: genomics and the changing nature of health information. Genome Medicine, 2(3), 18.PubMedCrossRef
go back to reference Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009). An agenda for personalized medicine. Nature, 461(7265), 724–726.PubMedCrossRef Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009). An agenda for personalized medicine. Nature, 461(7265), 724–726.PubMedCrossRef
go back to reference O’Daniel, J. M. (2010). The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. Journal of Genetic Counseling, 19(4), 315–327.PubMedCrossRef O’Daniel, J. M. (2010). The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. Journal of Genetic Counseling, 19(4), 315–327.PubMedCrossRef
go back to reference Ransohoff, D. F., & Khoury, M. J. (2010). Personal genomics: information can be harmful. European Journal of Clinical Investigation, 40(1), 64–68.PubMedCrossRef Ransohoff, D. F., & Khoury, M. J. (2010). Personal genomics: information can be harmful. European Journal of Clinical Investigation, 40(1), 64–68.PubMedCrossRef
go back to reference Scheuner, M. T. (2003). Genetic evaluation for coronary artery disease. Genetics in Medicine, 5(4), 269–285.PubMedCrossRef Scheuner, M. T. (2003). Genetic evaluation for coronary artery disease. Genetics in Medicine, 5(4), 269–285.PubMedCrossRef
go back to reference Scheuner, M. T., Whitworth, W. C., McGruder, H., Yoon, P. W., & Khoury, M. J. (2006). Expanding the definition of a positive family history for early-onset coronary heart disease. Genetics in Medicine, 8(8), 491–501.PubMedCrossRef Scheuner, M. T., Whitworth, W. C., McGruder, H., Yoon, P. W., & Khoury, M. J. (2006). Expanding the definition of a positive family history for early-onset coronary heart disease. Genetics in Medicine, 8(8), 491–501.PubMedCrossRef
go back to reference Scheuner, M. T., Sieverding, P., & Shekelle, P. G. (2008). Delivery of genomic medicine for common chronic adult diseases: a systematic review. Journal of the American Medical Association, 299(11), 1320–1334.PubMedCrossRef Scheuner, M. T., Sieverding, P., & Shekelle, P. G. (2008). Delivery of genomic medicine for common chronic adult diseases: a systematic review. Journal of the American Medical Association, 299(11), 1320–1334.PubMedCrossRef
go back to reference Soskolne, C. L., & Sieswerda, L. E. (2010). Cancer risk associated with pulp and paper mills: a review of occupational and community epidemiology. Chronic Diseases in Canada, 29(Suppl 2), 86–100.PubMed Soskolne, C. L., & Sieswerda, L. E. (2010). Cancer risk associated with pulp and paper mills: a review of occupational and community epidemiology. Chronic Diseases in Canada, 29(Suppl 2), 86–100.PubMed
go back to reference Stack, C. B., Gharani, N., Gordon, E. S., Schmidlen, T., Christman, M. F., & Keller, M. A. (2011). Genetic risk estimation in the Coriell Personalized Medicine Collaborative. Genetics in Medicine, 13(2), 131–139.PubMedCrossRef Stack, C. B., Gharani, N., Gordon, E. S., Schmidlen, T., Christman, M. F., & Keller, M. A. (2011). Genetic risk estimation in the Coriell Personalized Medicine Collaborative. Genetics in Medicine, 13(2), 131–139.PubMedCrossRef
go back to reference Swan, M. (2010). Multigenic condition risk assessment in direct-to-consumer genomic services. Genetics in Medicine, 12(5), 279–288.PubMedCrossRef Swan, M. (2010). Multigenic condition risk assessment in direct-to-consumer genomic services. Genetics in Medicine, 12(5), 279–288.PubMedCrossRef
go back to reference Wang, L. D., Zhou, F. Y., Li, X. M., Sun, L. D., Song, X., Jin, Y., et al. (2010). Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nature Genetics, 42(9), 759–763.PubMedCrossRef Wang, L. D., Zhou, F. Y., Li, X. M., Sun, L. D., Song, X., Jin, Y., et al. (2010). Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nature Genetics, 42(9), 759–763.PubMedCrossRef
go back to reference Watkins, S., Thorburn, D., Joshi, N., Neilson, M., Joyce, T., Spooner, R., et al. (2008). The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. European Journal of Gastroenterology and Hepatology, 20(5), 379–383.PubMedCrossRef Watkins, S., Thorburn, D., Joshi, N., Neilson, M., Joyce, T., Spooner, R., et al. (2008). The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. European Journal of Gastroenterology and Hepatology, 20(5), 379–383.PubMedCrossRef
go back to reference Yang, Q., Flanders, W. D., Moonesinghe, R., Ioannidis, J. P., Guessous, I., & Khoury, M. J. (2009). Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. American Journal of Human Genetics, 85(6), 786–800.PubMedCrossRef Yang, Q., Flanders, W. D., Moonesinghe, R., Ioannidis, J. P., Guessous, I., & Khoury, M. J. (2009). Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. American Journal of Human Genetics, 85(6), 786–800.PubMedCrossRef
Metadata
Title
Direct-to-Consumer Personal Genomic Testing: A Case Study and Practical Recommendations for “Genomic Counseling”
Authors
Amy C. Sturm
Kandamurugu Manickam
Publication date
01-06-2012
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 3/2012
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-012-9489-7

Other articles of this Issue 3/2012

Journal of Genetic Counseling 3/2012 Go to the issue